Accepted at 11:54 p.m. Apr, 29, 2025 by andrewmathias8
Author: IantheBFG
Co-authors: andrewmathias8
Related Note: 1540659414517 3
Rationale for change

Format change to what we usually use for these types of cards


Why have "2nd to antipsychotics" in both rows 2 and 3 when you can just put that in the original question prompt?

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Empty field
OME
Additional Resources
One by one
Empty field
#AK_Step2_v12::!Shelf::Neuro #AK_Other::!AK_UpdateTags::AnKing_Image::Mujeeb::Extrapyramidal_symptoms #AK_Step2_v12::#B&B::13_Psych::04_Psychopharmacology::02_Antipsychotics #AK_Step2_v12::Original_decks::Dorian::fam::ome::psych::pharm #AK_Step2_v12::#UWorld::COMLEX::104758 #AK_Step2_v12::#UWorld::COMLEX::101949 #AK_Step2_v12::#Resources_by_rotation::Psych::uworld::zanki #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Psychiatry::Extrapyramidal_symptoms #AK_Step2_v12::#UWorld::Step::20465 #AK_Other::!AK_UpdateTags::AnKing_Image::AhmedA::Extrapyramidal_Symptoms #AK_Step2_v12::#Resources_by_rotation::Psych::uworld::dorian #AK_Step1_v12::#AMBOSS::QjauZk #AK_Step2_v12::#UWorld::Step::2505 #AK_Step3_v12::#UWorld::6119 #AK_Step2_v12::#UWorld::Step::6915 #AK_Step2_v12::!Shelf::#Cards_AnKing_Did::5psych #AK_Step1_v12::#B&B::19_Psych::04_Pharm::03_Antipsychotics #PANCE::BEHAVIORAL::schizophrenia #AK_Step2_v12::#Resources_by_rotation::Psych::fapsych::pharm #PANCE::BEHAVIORAL::bipolar #AK_Step2_v12::#Subjects::Psychiatry::07_Psychotic_Disorders::*Antipsychotics::*Extrapyramidal_Side_Effects::Akithisia #AK_Step3_v12::#UWorld::5329 #AK_Step1_v12::#UWorld::COMLEX::106905 #AK_Step2_v12::#AMBOSS::IzaY8M #AK_Step2_v12::#B&B::10_Neuro::03_Movement_Disorders::02_Movement_Disorders::Extra #AK_Step2_v12::#UWorld::COMLEX::103686 #AK_Step1_v12::#UWorld::Step::105280 #AK_Step2_v12::#UWorld::#UWSA1 #AK_Step3_v12::#UWorld::7720 #AK_Step2_v12::#UWorld::COMLEX::28319 #AK_Other::!AK_UpdateTags::step2PotentialDupes::ausername::IMFM::06 #AK_Step2_v12::#OME::04_Psychiatry::15_Psych_Pharm_2 #AK_Other::!AK_UpdateTags::AnKing_Image::MS::Extrapyramidal_symptoms #AK_Step2_v12::#OME::Clinical::04_Psychiatry::15_Psych_Pharm_2 #AK_Step2_v12::#Resources_by_rotation::FM::ome::psych::pharm #AK_Step2_v12::!Shelf::FM #AK_Step2_v12::!Shelf::Psych #PANCE::EOR::PSYCH #AK_Step2_v12::#Subjects::Psychiatry::07_Psychotic_Disorders::*Antipsychotics::*Extrapyramidal_Side_Effects::Acute_Dystonia #AK_Step2_v12::Original_decks::Dorian::neuro::nbme #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step2_v12::#FirstAid::13_Psych::02_Psychotic_Disorders::02_Schizophreniform #AK_Step2_v12::Original_decks::Dorian::psych::fapsych::pharm #AK_Step2_v12::#Resources_by_rotation::Neuro::nbme #AK_Step2_v12::#NBME::Form09 #AK_Step2_v12::#UWorld::Step::17119 #AK_Step2_v12::#CMS::Psychiatry::Form_05 #AK_Step2_v12::#UWorld::Step::11898 #AK_Step2_v12::#NBME::Form14::Section_4 #AK_Step2_v12::#AMBOSS::SO0y7T